ArticlePharmaceutics2020
Antimicrobial Peptide against
Open access · goldAbstract read
In one paragraph
Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 30 citations in OpenAlex.
- Transmembrane delivery of antimicrobial peptides by engineered eCIS into macrophages for intracellular mycobacteria elimination.Science advances · 2026Article
- Antimicrobial peptides for tuberculosis in a post-antibiotic era: from in vitro promise to therapeutic potential.npj antimicrobials and resistance · 2026Review
- Review
- Redefining Therapies for Drug-Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design.Advanced healthcare materials · 2026Review
- Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026Review
- Autophagy andFrontiers in cellular and infection microbiology · 2026Review
- Autophagy in tuberculosis: advances, translational gaps, and the promise of host-directed therapies.Frontiers in cellular and infection microbiology · 2026Review
- Endogenous hepcidin plays an essential role inEmerging microbes & infections · 2025Article
- Pro-Dermcidin as an Emerging Regulator of Innate Immunity in Sepsis.International journal of molecular sciences · 2025Review
- Pro-dermcidin and derivatives as potential therapeutics for lethal experimental sepsis.Frontiers in immunology · 2025Article
- Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye.Trends in immunology · 2023Review
- The Use of Particulate Systems for Tuberculosis Prophylaxis and Treatment: Opportunities and Challenges.Microorganisms · 2023Review
- Embedded-AMP: A Multi-Thread Computational Method for the Systematic Identification of Antimicrobial Peptides Embedded in Proteome Sequences.Antibiotics (Basel, Switzerland) · 2023Article
- Antimicrobial peptides as drugs with double response againstFrontiers in microbiology · 2023Review
- Review
- ApoE Mimetic Peptide COG1410 Exhibits Strong Additive Interaction with Antibiotics AgainstInfection and drug resistance · 2023Article
- Article
- Antimicrobial peptides with cell-penetrating activity as prophylactic and treatment drugs.Bioscience reports · 2022Review
- Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria.Pharmaceutics · 2022Review
- Role of Antimicrobial Peptides in Treatment and Prevention of Mycobacterium Tuberculosis: A Review.International journal of peptide research and therapeutics · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 2 institutions in 1 country.
Erika A Peláez CoyotlDepartment of Biochemistry and Structural Biology, Institute of Cellular Physiology, National Autonomous University of Mexico (UNAM), 04510 Mexico City, Mexico.
Jacqueline Barrios PalaciosExperimental Pathology Section, National Institute of Medical Sciences and Nutrition Salvador Zubirán, 14080 Mexico City, Mexico.
Gabriel MuciñoDepartment of Neurodevelopment and Physiology, Instituto de Fisiologia Celular, National Autonomous University of Mexico, 04510 Mexico City, Mexico.
Daniel Moreno-BlasDepartment of Neurodevelopment and Physiology, Instituto de Fisiologia Celular, National Autonomous University of Mexico, 04510 Mexico City, Mexico.ORCID 0000-0002-8394-8205
Miguel CostasLaboratorio de Biofisicoquímica, Departamento de Fisicoquímica, Facultad de Química, Universidad Nacional Autonoma de Mexico, 04510 Mexico City, Mexico.ORCID 0000-0001-8604-6381
Teresa Montiel MontesDepartment of Molecular Neuropathology, Institute of Cellular Physiology, National Autonomous University of Mexico (UNAM), 04510 Mexico City, Mexico.
Christian DienerDepartment of Biochemistry and Structural Biology, Institute of Cellular Physiology, National Autonomous University of Mexico (UNAM), 04510 Mexico City, Mexico.
Salvador Uribe-CarvajalDepartment of Molecular Genetics, Institute of Cellular Physiology, National Autonomous University of Mexico, 04510 Mexico City, Mexico.
Lourdes MassieuDepartment of Molecular Neuropathology, Institute of Cellular Physiology, National Autonomous University of Mexico (UNAM), 04510 Mexico City, Mexico.
Susana Castro-ObregónDepartment of Neurodevelopment and Physiology, Instituto de Fisiologia Celular, National Autonomous University of Mexico, 04510 Mexico City, Mexico.ORCID 0000-0003-0549-5690
Octavio Ramos EspinosaExperimental Pathology Section, National Institute of Medical Sciences and Nutrition Salvador Zubirán, 14080 Mexico City, Mexico.ORCID 0000-0002-9010-4625
Dulce Mata EspinosaExperimental Pathology Section, National Institute of Medical Sciences and Nutrition Salvador Zubirán, 14080 Mexico City, Mexico.
Jorge Barrios-PayanExperimental Pathology Section, National Institute of Medical Sciences and Nutrition Salvador Zubirán, 14080 Mexico City, Mexico.
Juan Carlos León ContrerasExperimental Pathology Section, National Institute of Medical Sciences and Nutrition Salvador Zubirán, 14080 Mexico City, Mexico.ORCID 0000-0001-8827-1670
Gerardo CorzoDepartment of Molecular Medicine and Bioprocesses, Institute of Biotechnology, National Autonomous University of Mexico (UNAM), 62210 Cuernavaca Morelos, Mexico.ORCID 0000-0002-9513-1622
Rogelio Hernández-PandoExperimental Pathology Section, National Institute of Medical Sciences and Nutrition Salvador Zubirán, 14080 Mexico City, Mexico.
Gabriel Del RioDepartment of Biochemistry and Structural Biology, Institute of Cellular Physiology, National Autonomous University of Mexico (UNAM), 04510 Mexico City, Mexico.ORCID 0000-0002-8118-4985
Universidad Nacional Autónoma de México · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MX
Funding
Consejo Nacional de Ciencia y Tecnología 2015-2 FC-921Consejo Nacional de Ciencia y Tecnología CB252316Consejo Nacional de Ciencia y Tecnología FC2015-1/115Consejo Nacional de Ciencia y Tecnología FOIN-219Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IG100416Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IG100513Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IN206518Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IN208014Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IN208817
Abstract
PubMed holds no abstract for this paper.
Indexed as
antimicrobial peptideautophagyiztli peptidemultidrug resistanttuberculosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.